(1)
Abed, A.; Fezea, A. Serum Interleukin-6 As an Inflammatory Biomarker in Type 2 Diabetes Mellitus: Correlation With Diabetic Peripheral Neuropathy and Diagnostic Performance. RJDNMD 2026, 33, 365-372.